Every material Form 8-K CTS filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
CTS Corporation said Senior Vice President Martin Baumeister resigned effective December 5, 2025, to pursue another opportunity, and Senior Vice President Pratik Trivedi was appointed chief operating officer effective the same date. The filing says the resignation was not due to any disagreement with CTS and that no material new compensation or equity was granted to Trivedi for the role, so the change is a leadership transition with no stated financial terms.
Martin Baumeister resigned as Senior Vice President, effective close of business December 5, 2025; notice given November 21, 2025
Pratik Trivedi, 46, appointed chief operating officer effective December 5, 2025
Trivedi joined CTS in April 2024; previously VP, North America, mobility business at Eaton Corporation plc
CTS states no material contract, compensation change or equity grant was made in connection with the COO appointment
CTS Corporation entered a five-year, $300 million unsecured revolving credit agreement with Wells Fargo as administrative agent, terminating its prior $400 million facility. Proceeds from initial borrowings repaid $63.3 million owed under the prior agreement, and the filing describes covenants requiring a net leverage ratio of no more than 3.5 to 1.0 and an interest coverage ratio of at least 3.0 to 1.
New five-year unsecured revolving credit facility of $300 million, dated November 24, 2025
Replaces the prior $400 million unsecured credit facility, which was terminated as of November 24, 2025
Initial borrowings used to repay $63.3 million outstanding under the prior agreement
Covenants include a maximum net leverage ratio of 3.5 to 1.0 and a minimum interest coverage ratio of 3.0 to 1
CTS Corporation increased its board from seven to eight members and elected Kimberly MacKay to fill the new seat, effective November 5, 2025. MacKay is SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc., and will serve on the Nominating, Governance and Sustainability Committee and the Technology and Transactions Committee.
Board size increased from seven to eight members effective November 5, 2025
Kimberly MacKay is SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc.
MacKay will serve on the Nominating, Governance and Sustainability Committee and the Technology and Transactions Committee
The company will enter into an indemnification agreement with MacKay
CTS Corporation reported third quarter 2025 sales of $143 million, up 8% from a year earlier, with sales to diversified end markets up 22%. Net income fell to $14 million, or $0.46 per diluted share, from $18 million, or $0.59, and included a $4.2 million charge tied to an EPA past cost recovery claim. The company updated its 2025 guidance to sales of $535 million to $545 million and adjusted diluted EPS of $2.20 to $2.25.
Sales were $143 million, up 8%; transportation sales fell 7% and diversified end market sales rose 22%.
Net income was $14 million, or $0.46 per diluted share, versus $18 million, or $0.59, a year earlier.
Adjusted diluted EPS was $0.60, versus $0.61 a year earlier, including a $0.03 unfavorable impact from recent US tax legislation.
Updated 2025 guidance: sales of $535 million to $545 million and adjusted diluted EPS of $2.20 to $2.25.
CTS reported second-quarter 2025 sales of $135 million, up 4% from a year earlier, and diluted EPS of $0.62, up from $0.48. The company maintained its 2025 guidance of $520-$550 million in sales and adjusted diluted EPS of $2.20-$2.35, which signals no change to its outlook.
Sales were $135 million, up 4%; diversified end markets rose 13% while transportation fell 6%
Diluted EPS was $0.62 vs $0.48; adjusted diluted EPS was $0.57 vs $0.54
2025 guidance maintained: sales of $520-$550 million and adjusted diluted EPS of $2.20-$2.35
Operating cash flow was $28 million vs $20 million a year earlier
CTS Corporation appointed Mark Pacioni as Chief Legal & Administrative Officer and Corporate Secretary, effective July 1, 2025. He previously served as Chief Legal Officer and Secretary of CareerBuilder + Monster, and his compensation package includes a $375,000 base salary and a 55% target incentive opportunity.
Appointed effective July 1, 2025, with the company announcing it by press release the same day
Base salary of $375,000 and target management incentive of 55% of base salary
Equity grants of 4,600 time-based RSUs vesting over three years and 7,000 performance-based RSUs tied to financial objectives over three years
Prior role: Chief Legal Officer and Secretary of CareerBuilder + Monster, April 2019 to June 2025
CTS reported first quarter 2025 results, with sales flat year over year at $126 million. Diversified end-market sales rose 14%, while transportation sales fell 12%, and GAAP diluted EPS rose to $0.44 from $0.36, but adjusted diluted EPS fell to $0.44 from $0.47. The company kept its 2025 guidance of $520 million to $550 million in sales and $2.20 to $2.35 in adjusted diluted EPS.
Sales were $126 million, flat year over year; diversified end-market sales rose 14% and transportation sales fell 12%.
GAAP diluted EPS was $0.44 versus $0.36 a year earlier; adjusted diluted EPS was $0.44 versus $0.47.
Operating cash flow was $16 million, compared with $18 million in the first quarter of 2024.
2025 guidance was maintained: sales of $520 million to $550 million and adjusted diluted EPS of $2.20 to $2.35.
CTS Corporation disclosed that Scott D'Angelo, its Vice President, Chief Legal and Administrative Officer and Corporate Secretary, resigned on March 5, 2025, effective April 4, 2025. The company said the departure was a personal decision to pursue another chief legal officer opportunity and was not the result of any disagreement with the company.
Scott D'Angelo submitted his resignation on March 5, 2025, effective April 4, 2025.
He holds the roles of Vice President, Chief Legal and Administrative Officer and Corporate Secretary.
He will remain in these roles until the effective date.
The filing states the resignation was not the result of any disagreement with the company.
CTS Corporation reported fourth-quarter and full-year 2024 results on February 4, 2025. Q4 sales rose 2% to $127 million, but GAAP diluted EPS fell to $0.45 from $0.49, while adjusted diluted EPS rose to $0.53 from $0.47. For 2025, the company expects sales of $520 million to $550 million and adjusted diluted EPS of $2.20 to $2.35, compared with 2024 adjusted EPS of $2.17.
Q4 2024 sales were $127 million, up 2% year over year; the SyQwest acquisition added $11 million.
Full-year 2024 sales were $516 million, down 6%; full-year diluted EPS was $1.89 versus $1.92 in 2023.
Full-year 2024 operating cash flow was $99 million, up from $89 million in 2023.
2025 guidance: sales of $520 million to $550 million and adjusted diluted EPS of $2.20 to $2.35.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CTS filing is on SEC EDGAR ↗. 8-K briefs of other companies →